BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hsue PY, Giri K, Erickson S, MacGregor JS, Younes N, Shergill A, Waters DD. Clinical features of acute coronary syndromes in patients with human immunodeficiency virus infection. Circulation. 2004;109:316-319. [PMID: 14718406 DOI: 10.1161/01.cir.0000114520.38748.aa] [Cited by in Crossref: 145] [Cited by in F6Publishing: 54] [Article Influence: 8.1] [Reference Citation Analysis]
Number Citing Articles
1 Hyle EP, Mayosi BM, Middelkoop K, Mosepele M, Martey EB, Walensky RP, Bekker LG, Triant VA. The association between HIV and atherosclerotic cardiovascular disease in sub-Saharan Africa: a systematic review. BMC Public Health 2017;17:954. [PMID: 29246206 DOI: 10.1186/s12889-017-4940-1] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 4.2] [Reference Citation Analysis]
2 Bundhun PK, Pursun M, Huang WQ. Does infection with human immunodeficiency virus have any impact on the cardiovascular outcomes following percutaneous coronary intervention?: a systematic review and meta-analysis. BMC Cardiovasc Disord 2017;17:190. [PMID: 28716008 DOI: 10.1186/s12872-017-0624-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
3 Funderburg NT, Mayne E, Sieg SF, Asaad R, Jiang W, Kalinowska M, Luciano AA, Stevens W, Rodriguez B, Brenchley JM, Douek DC, Lederman MM. Increased tissue factor expression on circulating monocytes in chronic HIV infection: relationship to in vivo coagulation and immune activation. Blood 2010;115:161-7. [PMID: 19828697 DOI: 10.1182/blood-2009-03-210179] [Cited by in Crossref: 175] [Cited by in F6Publishing: 178] [Article Influence: 13.5] [Reference Citation Analysis]
4 Hsue PY, Hunt PW, Sinclair E, Bredt B, Franklin A, Killian M, Hoh R, Martin JN, McCune JM, Waters DD, Deeks SG. Increased carotid intima-media thickness in HIV patients is associated with increased cytomegalovirus-specific T-cell responses. AIDS 2006;20:2275-83. [PMID: 17117013 DOI: 10.1097/QAD.0b013e3280108704] [Cited by in Crossref: 213] [Cited by in F6Publishing: 134] [Article Influence: 13.3] [Reference Citation Analysis]
5 Ross AC, Armentrout R, O'Riordan MA, Storer N, Rizk N, Harrill D, El Bejjani D, McComsey GA. Endothelial activation markers are linked to HIV status and are independent of antiretroviral therapy and lipoatrophy. J Acquir Immune Defic Syndr 2008;49:499-506. [PMID: 18989230 DOI: 10.1097/QAI.0b013e318189a794] [Cited by in Crossref: 52] [Cited by in F6Publishing: 28] [Article Influence: 4.0] [Reference Citation Analysis]
6 Boccara F, Mary-Krause M, Potard V, Teiger E, Lang S, Hammoudi N, Chauvet M, Ederhy S, Dufour-Soulat L, Ancedy Y, Nhan P, Adavane S, Steg PG, Funck-Brentano C, Costagliola D, Cohen A; PACS‐HIV (Prognosis of Acute Coronary Syndrome in HIV‐Infected Patients) Investigators †. HIV Infection and Long-Term Residual Cardiovascular Risk After Acute Coronary Syndrome. J Am Heart Assoc 2020;9:e017578. [PMID: 32844734 DOI: 10.1161/JAHA.119.017578] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
7 Bloomfield GS, Hogan JW, Keter A, Holland TL, Sang E, Kimaiyo S, Velazquez EJ. Blood pressure level impacts risk of death among HIV seropositive adults in Kenya: a retrospective analysis of electronic health records. BMC Infect Dis 2014;14:284. [PMID: 24886474 DOI: 10.1186/1471-2334-14-284] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
8 Ebner B, Vincent L, Grant J, Martinez C. Cardiac Catheterization Procedures in Patients with HIV: A Retrospective Analysis. J Cardiovasc Dev Dis 2021;8:33. [PMID: 33801600 DOI: 10.3390/jcdd8040033] [Reference Citation Analysis]
9 Neuenburg JK, Furlan S, Bacchetti P, Price RW, Grant RM. Enrichment of activated monocytes in cerebrospinal fluid during antiretroviral therapy. AIDS 2005;19:1351-9. [PMID: 16103765 DOI: 10.1097/01.aids.0000181008.39514.ee] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
10 Romancini JLH, Guariglia D, Nardo Jr. N, Herold P, Pimentel GGDA, Pupulin ÁRT. Níveis de atividade física e alterações metabólicas em pessoas vivendo com HIV/AIDS. Rev Bras Med Esporte 2012;18:356-60. [DOI: 10.1590/s1517-86922012000600001] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
11 Feinstein MJ, Bogorodskaya M, Bloomfield GS, Vedanthan R, Siedner MJ, Kwan GF, Longenecker CT. Cardiovascular Complications of HIV in Endemic Countries. Curr Cardiol Rep 2016;18:113. [PMID: 27730474 DOI: 10.1007/s11886-016-0794-x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
12 Bhatia R, Ryscavage P, Taiwo B. Accelerated aging and human immunodeficiency virus infection: emerging challenges of growing older in the era of successful antiretroviral therapy. J Neurovirol 2012;18:247-55. [PMID: 22205585 DOI: 10.1007/s13365-011-0073-y] [Cited by in Crossref: 50] [Cited by in F6Publishing: 44] [Article Influence: 4.5] [Reference Citation Analysis]
13 Liu Y, Chen Y, Hao Y, Xiao J, Li B, Zhang L, Han J, Zhao H, Nguyen TN. Assessment of Clinical Features in HIV-Infected Patients with Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention in China. Journal of Interventional Cardiology 2022;2022:1-8. [DOI: 10.1155/2022/8351304] [Reference Citation Analysis]
14 Tseng ZH, Secemsky EA, Dowdy D, Vittinghoff E, Moyers B, Wong JK, Havlir DV, Hsue PY. Sudden cardiac death in patients with human immunodeficiency virus infection. J Am Coll Cardiol 2012;59:1891-6. [PMID: 22595409 DOI: 10.1016/j.jacc.2012.02.024] [Cited by in Crossref: 164] [Cited by in F6Publishing: 158] [Article Influence: 16.4] [Reference Citation Analysis]
15 Zanni MV, Schouten J, Grinspoon SK, Reiss P. Risk of coronary heart disease in patients with HIV infection. Nat Rev Cardiol. 2014;11:728-741. [PMID: 25331088 DOI: 10.1038/nrcardio.2014.167] [Cited by in Crossref: 67] [Cited by in F6Publishing: 69] [Article Influence: 8.4] [Reference Citation Analysis]
16 Longenecker CT, Funderburg NT, Jiang Y, Debanne S, Storer N, Labbato DE, Lederman MM, McComsey GA. Markers of inflammation and CD8 T-cell activation, but not monocyte activation, are associated with subclinical carotid artery disease in HIV-infected individuals. HIV Med 2013;14:385-90. [PMID: 23332012 DOI: 10.1111/hiv.12013] [Cited by in Crossref: 88] [Cited by in F6Publishing: 96] [Article Influence: 9.8] [Reference Citation Analysis]
17 Mondal P, Aljizeeri A, Small G, Malhotra S, Harikrishnan P, Affandi JS, Buechel RR, Dwivedi G, Al-Mallah MH, Jain D. Coronary artery disease in patients with human immunodeficiency virus infection. J Nucl Cardiol 2021;28:510-30. [PMID: 32820424 DOI: 10.1007/s12350-020-02280-4] [Reference Citation Analysis]
18 Funderburg NT, Mehta NN. Lipid Abnormalities and Inflammation in HIV Inflection. Curr HIV/AIDS Rep 2016;13:218-25. [PMID: 27245605 DOI: 10.1007/s11904-016-0321-0] [Cited by in Crossref: 47] [Cited by in F6Publishing: 46] [Article Influence: 9.4] [Reference Citation Analysis]
19 Neumann T, Lülsdorf KA, Krings P, Reinsch N, Erbel R. [Coronary artery disease in HIV-infected subjects. Results of 101 coronary angiographies]. Herz 2011;36:18-23. [PMID: 21181097 DOI: 10.1007/s00059-010-3410-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
20 Funderburg NT, Zidar DA, Shive C, Lioi A, Mudd J, Musselwhite LW, Simon DI, Costa MA, Rodriguez B, Sieg SF. Shared monocyte subset phenotypes in HIV-1 infection and in uninfected subjects with acute coronary syndrome. Blood. 2012;120:4599-4608. [PMID: 23065151 DOI: 10.1182/blood-2012-05-433946] [Cited by in Crossref: 138] [Cited by in F6Publishing: 140] [Article Influence: 13.8] [Reference Citation Analysis]
21 Johns K, Saeedi R, Mancini GB, Bondy G. Ankle brachial index screening for occult vascular disease is not useful in HIV-positive patients. AIDS Res Hum Retroviruses 2010;26:955-9. [PMID: 20718628 DOI: 10.1089/aid.2009.0275] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
22 Cardenas VA, Meyerhoff DJ, Studholme C, Kornak J, Rothlind J, Lampiris H, Neuhaus J, Grant RM, Chao LL, Truran D, Weiner MW. Evidence for ongoing brain injury in human immunodeficiency virus-positive patients treated with antiretroviral therapy. J Neurovirol 2009;15:324-33. [PMID: 19499454 DOI: 10.1080/13550280902973960] [Cited by in Crossref: 87] [Cited by in F6Publishing: 97] [Article Influence: 7.3] [Reference Citation Analysis]
23 Boccara F, Teiger E, Cohen A, Ederhy S, Janower S, Odi G, Di Angelantonio E, Barbarini G, Barbaro G. Percutaneous coronary intervention in HIV infected patients: immediate results and long term prognosis. Heart. 2006;92:543-544. [PMID: 16537777 DOI: 10.1136/hrt.2005.068445] [Cited by in Crossref: 42] [Cited by in F6Publishing: 35] [Article Influence: 2.6] [Reference Citation Analysis]
24 Kagaruki GB, Mayige MT, Ngadaya ES, Kilale AM, Kahwa A, Shao AF, Kimaro GD, Manga CM, Mbata D, Materu GS, Masumo RM, Mfinanga SG. Knowledge and perception on type2 diabetes and hypertension among HIV clients utilizing care and treatment services: a cross sectional study from Mbeya and Dar es Salaam regions in Tanzania. BMC Public Health 2018;18:928. [PMID: 30055591 DOI: 10.1186/s12889-018-5639-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
25 Wongcharoen W, Khienprasit K, Phrommintikul A, Sukonthasarn A, Chattipakorn N. Heart rate variability and heart rate turbulence in HIV-infected patients receiving combination antiretroviral therapy. Ann Noninvasive Electrocardiol 2013;18:450-6. [PMID: 24047489 DOI: 10.1111/anec.12064] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
26 Kim DY, Chin BS, Baek JH, Lee JY, Moon J. Aggressive In-Stent Restenosis after Carotid Artery Stenting in a Patient with HIV Infection. J Clin Neurol 2021;17:134-6. [PMID: 33480210 DOI: 10.3988/jcn.2021.17.1.134] [Reference Citation Analysis]
27 Chan P, Spudich S. Investigating vascular diseases in people living with HIV by nuclear imaging. J Nucl Cardiol 2021. [PMID: 33884573 DOI: 10.1007/s12350-021-02613-x] [Reference Citation Analysis]
28 Funderburg NT. Markers of coagulation and inflammation often remain elevated in ART-treated HIV-infected patients. Curr Opin HIV AIDS 2014;9:80-6. [PMID: 24275673 DOI: 10.1097/COH.0000000000000019] [Cited by in Crossref: 61] [Cited by in F6Publishing: 40] [Article Influence: 7.6] [Reference Citation Analysis]
29 Hatleberg CI, Ryom L, El-Sadr W, Smith C, Weber R, Reiss P, Fontas E, Dabis F, Law M, Monforte Ad, De Wit S, Mocroft A, Phillips A, Lundgren JD, Sabin C; D:A:D Study Group. Improvements over time in short-term mortality following myocardial infarction in HIV-positive individuals. AIDS 2016;30:1583-96. [PMID: 26950315 DOI: 10.1097/QAD.0000000000001076] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
30 Ntusi NAB, Ntsekhe M. Human immunodeficiency virus-associated heart failure in sub-Saharan Africa: evolution in the epidemiology, pathophysiology, and clinical manifestations in the antiretroviral era. ESC Heart Fail 2016;3:158-67. [PMID: 28834662 DOI: 10.1002/ehf2.12087] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
31 Bares SH, Smeaton LM, Xu A, Godfrey C, McComsey GA. HIV-Infected Women Gain More Weight than HIV-Infected Men Following the Initiation of Antiretroviral Therapy. J Womens Health (Larchmt) 2018;27:1162-9. [PMID: 29608129 DOI: 10.1089/jwh.2017.6717] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 6.0] [Reference Citation Analysis]
32 Ammirati E, Moroni F, Magnoni M, Camici PG. The role of T and B cells in human atherosclerosis and atherothrombosis. Clin Exp Immunol 2015;179:173-87. [PMID: 25352024 DOI: 10.1111/cei.12477] [Cited by in Crossref: 80] [Cited by in F6Publishing: 76] [Article Influence: 11.4] [Reference Citation Analysis]
33 Grome HN, Barnett L, Hagar CC, Harrison DG, Kalams SA, Koethe JR. Association of T Cell and Macrophage Activation with Arterial Vascular Health in HIV. AIDS Res Hum Retroviruses 2017;33:181-6. [PMID: 27527002 DOI: 10.1089/AID.2016.0113] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 5.4] [Reference Citation Analysis]
34 Carballo D, Delhumeau C, Carballo S, Bähler C, Radovanovic D, Hirschel B, Clerc O, Bernasconi E, Fasel D, Schmid P, Cusini A, Fehr J, Erne P, Keller PF, Ledergerber B, Calmy A; Swiss HIV Cohort Study and AMIS registry. Increased mortality after a first myocardial infarction in human immunodeficiency virus-infected patients; a nested cohort study. AIDS Res Ther 2015;12:4. [PMID: 25705241 DOI: 10.1186/s12981-015-0045-z] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
35 Han WM, Law MG, Choi JY, Ditangco R, Kumarasamy N, Chaiwarith R, Ly PS, Khusuwan S, Merati TP, Do CD, Yunihastuti E, Azwa I, Lee MP, Pham TN, Chan YJ, Kiertiburanakul S, Ng OT, Tanuma J, Pujari S, Zhang F, Gani Y, Mave V, Ross J, Avihingsanon A; TREAT Asia HIV Observational Database of IeDEA Asia-Pacific. Weight changes, metabolic syndrome and all-cause mortality among Asian adults living with HIV. HIV Med 2021. [PMID: 34816562 DOI: 10.1111/hiv.13211] [Reference Citation Analysis]
36 Funderburg NT, Jiang Y, Debanne SM, Storer N, Labbato D, Clagett B, Robinson J, Lederman MM, McComsey GA. Rosuvastatin treatment reduces markers of monocyte activation in HIV-infected subjects on antiretroviral therapy. Clin Infect Dis. 2014;58:588-595. [PMID: 24253250 DOI: 10.1093/cid/cit748] [Cited by in Crossref: 89] [Cited by in F6Publishing: 96] [Article Influence: 9.9] [Reference Citation Analysis]
37 Spieker LE, Karadag B, Binggeli C, Corti R. Rapid progression of atherosclerotic coronary artery disease in patients with human immunodeficiency virus infection. Heart Vessels 2005;20:171-4. [PMID: 16025368 DOI: 10.1007/s00380-004-0790-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
38 Lembas A, Zawartko K, Sapuła M, Mikuła T, Kozłowska J, Wiercińska-drapało A. VCAM-1 as a Biomarker of Endothelial Function among HIV-Infected Patients Receiving and Not Receiving Antiretroviral Therapy. Viruses 2022;14:578. [DOI: 10.3390/v14030578] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
39 Funderburg NT, Jiang Y, Debanne SM, Labbato D, Juchnowski S, Ferrari B, Clagett B, Robinson J, Lederman MM, McComsey GA. Rosuvastatin reduces vascular inflammation and T-cell and monocyte activation in HIV-infected subjects on antiretroviral therapy. J Acquir Immune Defic Syndr 2015;68:396-404. [PMID: 25514794 DOI: 10.1097/QAI.0000000000000478] [Cited by in Crossref: 106] [Cited by in F6Publishing: 83] [Article Influence: 15.1] [Reference Citation Analysis]
40 Alkhalil M, Conlon CP, Ashrafian H, Choudhury RP. Aggressive restenosis after percutaneous intervention in two coronary loci in a patient with human immunodeficiency virus infection. World J Clin Cases 2017; 5(2): 40-45 [PMID: 28255546 DOI: 10.12998/wjcc.v5.i2.40] [Reference Citation Analysis]
41 Kagaruki GB, Mayige MT, Ngadaya ES, Kimaro GD, Kalinga AK, Kilale AM, Kahwa AM, Materu GS, Mfinanga SG. Magnitude and risk factors of non-communicable diseases among people living with HIV in Tanzania: a cross sectional study from Mbeya and Dar es Salaam regions. BMC Public Health 2014;14:904. [PMID: 25183300 DOI: 10.1186/1471-2458-14-904] [Cited by in Crossref: 26] [Cited by in F6Publishing: 35] [Article Influence: 3.3] [Reference Citation Analysis]
42 Marcus JL, Hurley LB, Prasad A, Zaroff J, Klein DB, Horberg MA, Go AS, DeLorenze GN, Quesenberry CP Jr, Sidney S, Lo JC, Silverberg MJ. Recurrence after hospitalization for acute coronary syndrome among HIV-infected and HIV-uninfected individuals. HIV Med 2019;20:19-26. [PMID: 30178911 DOI: 10.1111/hiv.12670] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
43 Glesby MJ. Coronary heart disease in HIV-infected patients. Curr HIV/AIDS Rep 2005;2:68-73. [PMID: 16091251 DOI: 10.1007/s11904-005-0021-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
44 Triant VA, Grinspoon SK. Epidemiology of ischemic heart disease in HIV. Curr Opin HIV AIDS 2017;12:540-7. [PMID: 28799997 DOI: 10.1097/COH.0000000000000410] [Cited by in Crossref: 22] [Cited by in F6Publishing: 13] [Article Influence: 5.5] [Reference Citation Analysis]
45 Hsue PY, Waters DD. HIV infection and coronary heart disease: mechanisms and management. Nat Rev Cardiol 2019;16:745-59. [PMID: 31182833 DOI: 10.1038/s41569-019-0219-9] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 11.3] [Reference Citation Analysis]
46 Lorgis L, Cottenet J, Molins G, Benzenine E, Zeller M, Aube H, Touzery C, Hamblin J, Gudjoncik A, Cottin Y, Quantin C. Outcomes After Acute Myocardial Infarction in HIV-Infected Patients: Analysis of Data From a French Nationwide Hospital Medical Information Database. Circulation 2013;127:1767-74. [DOI: 10.1161/circulationaha.113.001874] [Cited by in Crossref: 85] [Cited by in F6Publishing: 35] [Article Influence: 9.4] [Reference Citation Analysis]
47 Zanetti HR, Mendes EL, Palandri Chagas AC, Gomes Douglas MO, Paranhos Lopes LT, Roever L, Gonçalves A, Santos Resende E. Triad of the Ischemic Cardiovascular Disease in People Living with HIV? Association Between Risk Factors, HIV Infection, and Use of Antiretroviral Therapy. Curr Atheroscler Rep 2018;20:30. [PMID: 29777448 DOI: 10.1007/s11883-018-0727-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
48 Lima GSD, Cavalcante TDMC, Isabella APJ, Magalhães ADS. Assistência de enfermagem a um paciente infartado portador de HIV, baseada na teoria do autocuidado: estudo de caso. Acta paul enferm 2007;20:452-7. [DOI: 10.1590/s0103-21002007000400011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
49 Boccara F. Cardiovascular complications and atherosclerotic manifestations in the HIV-infected population: type, incidence and associated risk factors. AIDS 2008;22 Suppl 3:S19-26. [PMID: 18845918 DOI: 10.1097/01.aids.0000327512.76126.6e] [Cited by in Crossref: 60] [Cited by in F6Publishing: 54] [Article Influence: 4.3] [Reference Citation Analysis]
50 Schneider S, Spinner CD, Cassese S, Promny D, Hapfelmeier A, Byrne RA, Baumann M, Jäger H, Steinlechner E, Laugwitz KL, Kastrati A. Association of increased CD8+ and persisting C-reactive protein levels with restenosis in HIV patients after coronary stenting. AIDS 2016;30:1413-21. [PMID: 26891035 DOI: 10.1097/QAD.0000000000001063] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
51 Becker AC, Libhaber E, Sliwa K, Singh S, Stewart S, Tikly M, Essop MR. Antiphospholipid antibodies in black south africans with hiv and acute coronary syndromes: prevalence and clinical correlates. BMC Res Notes 2011;4:379. [PMID: 21970576 DOI: 10.1186/1756-0500-4-379] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
52 Rana MA, Beedupalli J, Akkus NI. Unusual Response of Subclavian In-Stent Restenosis to Balloon Angioplasty in a Patient with HIV. Case Rep Vasc Med 2015;2015:157623. [PMID: 25685591 DOI: 10.1155/2015/157623] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
53 Feinstein MJ, Hsue PY, Benjamin LA, Bloomfield GS, Currier JS, Freiberg MS, Grinspoon SK, Levin J, Longenecker CT, Post WS. Characteristics, Prevention, and Management of Cardiovascular Disease in People Living With HIV: A Scientific Statement From the American Heart Association. Circulation 2019;140:e98-e124. [PMID: 31154814 DOI: 10.1161/CIR.0000000000000695] [Cited by in Crossref: 123] [Cited by in F6Publishing: 66] [Article Influence: 41.0] [Reference Citation Analysis]
54 Schwartz JB, Moore KL, Yin M, Sharma A, Merenstein D, Islam T, Golub ET, Tien PC, Adeyemi OM. Relationship of vitamin D, HIV, HIV treatment, and lipid levels in the Women's Interagency HIV Study of HIV-infected and uninfected women in the United States. J Int Assoc Provid AIDS Care 2014;13:250-9. [PMID: 24668135 DOI: 10.1177/2325957413506748] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
55 Klein MD, Keen SK, Sanka P, Senter E, Lin FC, Jones H, Vandermolen JL, Simpson RJ Jr. Social Disparities among Sudden Death victims with HIV. AIDS Behav 2022. [PMID: 35672553 DOI: 10.1007/s10461-022-03723-4] [Reference Citation Analysis]
56 Dirajlal-Fargo S, El Kamari V, Sattar A, Alam K, Funderburg N, Labbato D, Pirro L, Longenecker CT, Wilson WH, McComsey GA. Effect of statin on arginine metabolites in treated HIV-infection. Atherosclerosis 2017;266:74-80. [PMID: 28992467 DOI: 10.1016/j.atherosclerosis.2017.09.030] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
57 O'Dwyer EJ, Bhamra-Ariza P, Rao S, Emmanuel S, Carr A, Holloway CJ. Lower coronary plaque burden in patients with HIV presenting with acute coronary syndrome. Open Heart 2016;3:e000511. [PMID: 28123757 DOI: 10.1136/openhrt-2016-000511] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
58 Triant VA. Cardiovascular disease and HIV infection. Curr HIV/AIDS Rep 2013;10:199-206. [PMID: 23793823 DOI: 10.1007/s11904-013-0168-6] [Cited by in Crossref: 90] [Cited by in F6Publishing: 79] [Article Influence: 10.0] [Reference Citation Analysis]
59 Yilmaz A, Jennbacken K, Fogelstrand L. Reduced IgM levels and elevated IgG levels against oxidized low-density lipoproteins in HIV-1 infection. BMC Infect Dis 2014;14:143. [PMID: 24636004 DOI: 10.1186/1471-2334-14-143] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
60 Yuan N, Scherzer R, Tanriverdi K, Martin J, Rahalkar S, Hsue P. MicroRNA biomarkers associated with type 1 myocardial infarction in HIV-positive individuals. AIDS 2019;33:2351-61. [PMID: 31764100 DOI: 10.1097/QAD.0000000000002368] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
61 Hsue PY, Scherzer R, Hunt PW, Schnell A, Bolger AF, Kalapus SC, Maka K, Martin JN, Ganz P, Deeks SG. Carotid Intima-Media Thickness Progression in HIV-Infected Adults Occurs Preferentially at the Carotid Bifurcation and Is Predicted by Inflammation. J Am Heart Assoc 2012;1:jah3-e000422. [PMID: 23130122 DOI: 10.1161/JAHA.111.000422] [Cited by in Crossref: 54] [Cited by in F6Publishing: 48] [Article Influence: 5.4] [Reference Citation Analysis]
62 Parks MM, Secemsky EA, Yeh RW, Shen C, Choi E, Kazi DS, Hsue PY. Longitudinal management and outcomes of acute coronary syndrome in persons living with HIV infection. Eur Heart J Qual Care Clin Outcomes 2021;7:273-9. [PMID: 33226071 DOI: 10.1093/ehjqcco/qcaa088] [Reference Citation Analysis]
63 Han J, Zhao H, Ma Y, Zhou H, Hao Y, Li Y, Song C, Han N, Liu X, Zeng H, Qin M. Highly Active Antiretroviral Therapy (HAART)-Related Hypertriglyceridemia Is Associated With Failure of Recovery of CD14lowCD16+ Monocyte Subsets in AIDS Patients. Medicine (Baltimore) 2015;94:e1115. [PMID: 26166108 DOI: 10.1097/MD.0000000000001115] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
64 Feinstein MJ, Nance RM, Delaney JAC, Heckbert SR, Budoff MJ, Drozd DR, Burkholder GA, Willig JH, Mugavero MJ, Mathews WC, Moore RD, Eron JJ, Napravnik S, Hunt PW, Geng E, Hsue P, Peter I, Lober WB, Crothers K, Grunfeld C, Saag MS, Kitahata MM, Lloyd-Jones DM, Crane HM. Mortality following myocardial infarction among HIV-infected persons: the Center for AIDS Research Network Of Integrated Clinical Systems (CNICS). BMC Med 2019;17:149. [PMID: 31362721 DOI: 10.1186/s12916-019-1385-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
65 D’Ascenzo F, Cerrato E, Biondi-Zoccai G, Moretti C, Omedè P, Sciuto F, Bollati M, Modena MG, Gaita F, Sheiban I. Acute coronary syndromes in human immunodeficiency virus patients: a meta-analysis investigating adverse event rates and the role of antiretroviral therapy. Eur Heart J. 2012;33:875-880. [PMID: 22187508 DOI: 10.1093/eurheartj/ehr456] [Cited by in Crossref: 77] [Cited by in F6Publishing: 72] [Article Influence: 7.0] [Reference Citation Analysis]
66 Eugenin EA, Morgello S, Klotman ME, Mosoian A, Lento PA, Berman JW, Schecter AD. Human immunodeficiency virus (HIV) infects human arterial smooth muscle cells in vivo and in vitro: implications for the pathogenesis of HIV-mediated vascular disease. Am J Pathol. 2008;172:1100-1111. [PMID: 18310503 DOI: 10.2353/ajpath.2008.070457] [Cited by in Crossref: 78] [Cited by in F6Publishing: 77] [Article Influence: 5.6] [Reference Citation Analysis]